v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities    
Net income (loss) $ 3,229,957 $ (15,979,351)
Adjustments for non-cash items in net income (loss):    
Depreciation of property and equipment 702,258 993,379
Depreciation of property and equipment included in costs of finished cannabis inventory sold 2,140,694 436,047
Lease costs included in costs of finished cannabis inventory sold 549,964 328,957
Share-based compensation 2,393,994 1,608,823
Interest expense 150,331
Accretion expense 1,234,423 1,836,440
Other income (165,743)
Interest income (149,149)
Unrealized (gain) loss on derivative liability (44,917) 7,754,402
Realized (gain) loss on derivative liability (5,859,744) 5,049,209
Unrealized gain on warrant asset (247,477) (3,094,413)
Realized loss on warrant liability 1,741,710
Loss on equity investment in associate 452,962 251,230
Loss on disposal of property and equipment (50,057)
Deferred income taxes (830,655) (112,198)
Changes in non-cash working capital (Note 23) 12,897 1,850,802
Net cash provided by operating activities 3,569,795 2,614,980
Investing activities    
Purchase of property and equipment (4,659,006) (4,082,154)
Acquisition of Golden Harvests LLC (437,375)
Acquisition of Canopy Management, LLC (173,157) (271,438)
Dividend issued from Golden Harvests, LLC to minority owner (115,000) (530,000)
Advance of notes receivable (250,000) (1,547,678)
Repayment of notes receivable 266,417
Investment in ABCO Garden State, LLC (1,980,000)
Cash acquired on investment in ABCO Garden State, LLC 2,815
Advance on purchase of remaining Rogue EBC, LLC equity interest (1,235,855) (827,197)
Net cash used in investing activities (6,870,393) (8,969,235)
Financing activities    
Proceeds from exercise of stock options 406,944 359,958
Proceeds from exercise of warrants 4,609,577
Proceeds from long-term debt 12,630,345 450,000
Debt issuance costs (739,313) (126,914)
Repayment of long-term debt (2,467,521) (1,141,437)
Payment of interest on convertible debentures (79,755) (453,439)
Proceeds from sale of units of subsidiary 787,500
Net cash provided by financing activities 9,750,700 4,485,245
Effect of foreign exchange on cash and cash equivalents 4,024 (17,861)
Change in cash and cash equivalents 6,454,126 (1,886,871)
Cash and cash equivalents, beginning of year 4,917,708 6,804,579
Cash and cash equivalents, ending of year $ 11,371,834 $ 4,917,708